Results 41 to 50 of about 25,222 (249)
Journal of Hospital Medicine, EarlyView.Abstract Patients with substance use disorder (SUD) represent a high‐complexity, high‐cost population on hospital medicine services, yet their admissions are systematically under‐reimbursed due to narrow clinical documentation. Increasingly, hospital‐based addiction consultation service (ACS) clinicians provide dedicated addiction care to medically ...
Philip A. Durney +2 more
wiley +1 more source
Naltrexone therapeutic drug monitoring: A case series
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Naltrexone is an opioid receptor antagonist.It is used in maintanence treatment of opiate dependence,alcohol dependence, prevention of relapse of alcohol dependence, treatment of cocaine dependence, nicotine dependence, eating disorders ...
Birim Sungu Danışmant +3 more
doaj
BMC Psychiatry, 2005 Background Naltrexone is an effective medication for treatment of alcohol dependence, but its efficacy is limited by lack of adherence to the oral dosage form. A long-acting depot formulation of naltrexone may increase adherence. Methods A single site, 6-
Koch Monika +3 more
doaj +1 more source
Ringtail (Bassariscus astutus) survival in southwestern Oregon
The Journal of Wildlife Management, EarlyView.We captured and monitored radio‐collared ringtails over 2 years to estimate monthly and annual survival rates. We found that annual survival rates were much higher within forested landscapes in Oregon than for populations in the southwestern United States.
Lindsay N. Somers +2 more
wiley +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley +1 more source
Обозрение психиатрии и медицинской психологии имени В.М. БехтереваThe article overviews the results of the studies of different formulations of opioid antagonist naltrexone (oral, injectable and implantable) for stabilization of remission and relapse prevention in patients with opioid dependence conducted by authors ...
E. M. Krupitsky +3 more
doaj +1 more source
Trials, 2021 Background There is a lack of effective pharmacotherapy for prolonged grief disorder (PGD). Evidence suggests that the neurobiology of PGD involves the same circuitry as the reward pathway.
James Gang +4 more
doaj +1 more source
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
, 2018 [Background and Purpose] The aim of this study was to explore if the administration of naltrexone together with cannabidiol (CBD) may improve the efficacy in reducing alcohol consumption and motivation rather than any of the drugs given separately ...
García-Gutiérrez, María Salud +12 more
core +1 more source
, 2003 The aim of this study was to investigate the association between prior exposure to naltrexone and increased risk of fatal heroin overdose using a review of toxicology reports for heroin-related fatalities between July 1997 to August 1999 for two groups ...
Hulse, Gary K +13 more
core +1 more source
Medicinal Research Reviews, EarlyView.ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu +15 more
wiley +1 more source